indazoles has been researched along with Neoplasms, Skull Base in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, H; Kawashima, M; Kobayashi, H; Saito, N; Shin, M; Shinya, Y; Takahashi, W | 1 |
| Milhem, M; Stein, J; Vaena, D | 1 |
1 review(s) available for indazoles and Neoplasms, Skull Base
| Article | Year |
|---|---|
Clinical outcomes and toxicities of pazopanib administered orally in crushed form: Case reports and review of the literature.
Topics: Adult; Aged; Carcinoma, Renal Cell; Chordoma; Female; Humans; Indazoles; Kidney Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Skull Base Neoplasms; Sulfonamides | 2020 |
1 other study(ies) available for indazoles and Neoplasms, Skull Base
| Article | Year |
|---|---|
Stereotactic radiosurgery as a primary treatment for metastatic skull base alveolar soft part sarcoma: a case report.
Topics: Angiogenesis Inhibitors; Female; Humans; Indazoles; Pyrimidines; Radiosurgery; Sarcoma, Alveolar Soft Part; Skull Base Neoplasms; Sulfonamides; Temporal Bone; Young Adult | 2021 |